Promotions within GENEO Capital Entrepreneur, Louis Charrier and Marie Kirch as Director and Investment Director.

Promotions within GENEO Capital Entrepreneur, Louis Charrier and Marie Kirch as Director and Investment Director.

Promotions within GENEO Capital Entrepreneur, Louis Charrier and Marie Kirch as Director and Investment Director.

GENEO Capital Entrepreneur acquires a stake in ACS - Assurances voyage & expatriation, to support the group's growth and the evolution of its governance.

GENEO Capital Entrepreneur and SIPAREX Mezzanine support Egis in its external growth and impact plan through the issue of Relance Bonds.
Founded in France nearly 100 years ago, Egis is an international group operating in the fields of consulting, construction engineering, mobility and sustainability.

Nicolas Lapeyre joins GENEO Capital Entrepreneur as Director of Development. In this role, he will be responsible for pursuing and amplifying the growth of GENEO Capital Entrepreneur, which, after almost five years in existence, now has over €550 million under management through its 3 investment vehicles dedicated to SMEs.

On the occasion of its 30th anniversary, the KARDHAM Group, France's leading independent and integrated player in professional real estate, announces that GENEO Capital Entrepreneur and Bpifrance are strengthening their presence in Kardham's capital, having been present alongside management since 2020 and 2016 respectively.

Otego, world leader in technical textiles, launches its marketplace to rethink industrial protection.

The Epiktet group, leader in home childcare with Kinougarde, continues its growth dynamic with the acquisition of Mômji, a specialist in English-speaking and creative childcare.

GENEO Capital Entrepreneur's Mission Committee held its first official meeting today, marking another concrete step in the transformation of GENEO into a mission-driven company, effective May 19, 2023. This committee will be responsible for monitoring the execution of the mission and the strategic and operational implementation of GENEO's raison d'être: "to provide the real economy with positive finance that reconciles performance and meaning".

GENEO Capital Entrepreneur supported GBNA Santé in the acquisition of three facilities from the Francheville Perigord Santé group, strengthening GBNA's position as a leading hospital group in the Nouvelle-Aquitaine region, with a total of 12 healthcare facilities. This acquisition, announced in June and formally completed in September, was partly financed by a capital increase in which GENEO Capital Entrepreneur, which has been supporting GBNA since 2021, participated along with UI Investissement.

ChapsVision, the data enhancement specialist, raises €90 million to accelerate its development on the European market through targeted acquisitions. This round of financing is led by Qualium Investissement with the participation of GENEO, and historical investors Tikehau Capital and Bpifrance, who have subscribed to this new round of funding.

Stéphanie Kordonian joins GENEO Capital Entrepreneur's team of investment professionals with extensive experience in the SME and ETI segment.
A graduate of ESSEC business school, Stéphanie is a corporate finance professional, specializing in SMEs.

The consortium formed by TURENNE GROUPE and GENEO Capital Entrepreneur has deployed the first €220 million tranche of Relance Bonds, and is now launching the new €117 million tranche.

GENEO Capital entrepreneur supports the Actéo group, which specializes in the manufacture (Théolaur) and distribution of paints and complementary products for the building industry (Théodore Maison de Peinture), in the evolution of its capital with a view to accelerating its development projects, notably around innovation, its low-carbon approach and digital. This transaction is part of a long-term, positive-impact investment strategy.

After 4 years marked by accelerated organic and external growth, HOPPEN has established itself as the French leader in phygital support for patients and healthcare establishments, reducing the workload of caregivers.

A benchmark player in its market and recently nominated for the French Tech 2030 award, the company is taking a new step forward with the acquisition of a stake in Après-demain SA, the parent company of Debiopharm™, a life sciences company, to accelerate its growth plan in Europe and consolidate its market leadership in digital solutions for patients before, during and after hospitalization.

Founded in 2019 by Fanny Letier and François Rivolier, GENEO Capital Entrepreneur currently manages over €600 million through three investment vehicles offering French companies, European leaders in their field, a wide range of financial products to support their growth over the long term.

Founded in 2019 by Fanny Letier and François Rivolier, GENEO Capital Entrepreneur currently manages over €600 million through three investment vehicles offering French companies, European leaders in their field, a wide range of financial products to support their growth over the long term.

Created in 1989, the Scutum Group has become one of the leaders in safety and security in Europe, providing technological solutions for protection and risk prevention, particularly through turnkey services for security, remote surveillance and fire detection.

Created in 1989, the Scutum Group has become one of the leaders in safety and security in Europe, providing technological solutions for protection and risk prevention, particularly through turnkey services for security, remote surveillance and fire detection.

Created in 1989, the Scutum Group has become one of the leaders in safety and security in Europe, providing technological solutions for protection and risk prevention, particularly through turnkey services for security, remote surveillance and fire detection.

Created in 1989, the Scutum Group has become one of the leaders in safety and security in Europe, providing technological solutions for protection and risk prevention, particularly through turnkey services for security, remote surveillance and fire detection.

GENEO Capital Entrepreneur is helping i-Run, the French leader in the sale of running, trail, outdoor, fitness and athletic products, to reorganize its capital in order to support its managerial transition and accelerate its development projects in France and Europe.

GENEO Capital Entrepreneur is helping i-Run, the French leader in the sale of running, trail, outdoor, fitness and athletic products, to reorganize its capital in order to support its managerial transition and accelerate its development projects in France and Europe.

GENEO Capital Entrepreneur is helping i-Run, the French leader in the sale of running, trail, outdoor, fitness and athletic products, to reorganize its capital in order to support its managerial transition and accelerate its development projects in France and Europe.

The Executive Committee of Safic-Alcan, together with its existing private equity partners EMZ partners, Sagard and Société Générale Capital Partenaires, are pleased to announce the start of their next project.

The Executive Committee of Safic-Alcan, together with its existing private equity partners EMZ partners, Sagard and Société Générale Capital Partenaires, are pleased to announce the start of their next project.

Paris, June 21, 2022 - The Zurflüh-Feller Group, the French leader and a major player in Europe in the manufacture of components for roller shutters, is leaving the fold of the industrial holding company Edify to welcome a pool of evergreen investors led by GENEO Capital Entrepreneur alongside the management team headed by Thierry Jeanmart. This transaction is part of a long-term positive impact investment approach.

GENEO Capital Entrepreneur, UI Investissement and Crédit Agricole Centre France are joining forces to support the very strong development of Neftys Pharma. This investment marks the opening of a new phase in the group's growth by giving it the means to lead the consolidation of the European market.

GENEO Capital Entrepreneur announces the setting up of Relance Bonds, within the framework of the programme subscribed by insurers and partially guaranteed by the State.
Odigo is an international player in the publishing of Contact Center as-a-Service (CCaS) cloud software solutions that manage conversations between consumers/citizens and brands. Thanks to this long-term financing, Odigo intends to continue deploying its growth strategy, while strengthening its employer brand and human capital.

The GENEO Mezzanine positive impact fund is designed to finance small and medium-sized companies in the form of quasi-equity (mezzanine). Unique in its approach, this fund aims not only to finance the growth of companies, but also to support them intensively in their innovation programme for positive impact, through a tailor-made coaching programme and significant financial incentives.

This first impact report is an opportunity for GENEO to present its unique approach to positive impact as an investor. Rationale, commitments, organisation, support for invested companies, investment process and endowment funds: find out how we operate and what progress we have made in this area in 2021.

Milan, May 05, 2022 - Through this strategic acquisition, PINETTE PEI is establishing itself as a leading European industrial player in the field of innovative sheet metal bending and cutting machines. This Franco-Italian partnership enables the two entities, which share a common DNA, to meet their customers' needs as closely as possible and to increase their positive environmental impact.

We are pleased to present our GENEO 2021 Report.

Despite economic and health uncertainties, the differentiating attributes of Entrepreneurial Capital, which masters time, provides human capital and an entrepreneurial ecosystem, allow us to move forward with an offensive and opportunistic mindset.

To demonstrate the value it places on its stakeholders, GENEO Partners organises their consultation and sets up a Stakeholder Committee. Its main mission is to make recommendations on the implementation of GENEO's raison d'être and to issue opinions on the main indicators measuring its impact.  

To demonstrate the value it places on its stakeholders, GENEO Partners organises their consultation and sets up a Stakeholder Committee. Its main mission is to make recommendations on the implementation of GENEO's raison d'être and to issue opinions on the main indicators measuring its impact.  

Announced in the government's recovery plan (March 4, 2021), the Relance Bonds aim to enable the continued development and investment of SMEs and SMIs by strengthening their capital base. They are financed up to 90% by the insurers participating in the operation and 10% by the participating management companies and third party investors.

OPINION. By avoiding the hectic pace of life of startups while giving people responsibility, mid-sized companies often offer a healthy environment for their employees. Their advantage: a long-term vision that allows them to promote a positive societal impact. By Fanny Letier and François Rivolier, co-founders of GENEO Capital Entrepreneur.

Paris, January 12, 2022 - The Kardham Group, the leading independent and integrated French player in professional real estate, announces the creation of the Kardham Germany holding company with, as its first transaction, the acquisition of P.O.T. GmbH, a consultancy and support company for the development of professional workspaces.

THE HOPPEN GROUP, LEADER IN PHYGITAL PATIENT SUPPORT, INCREASES ITS CAPACITY TO ASSIST HEALTHCARE INSTITUTIONS AND CONSOLIDATES ITS POSITION AS FRENCH LEADER IN PATIENT SERVICES, BY ACQUIRING AKLIA, A SPECIALIST IN HOSPITAL MULTIMEDIA

The whole GENEO team wishes you a wonderful holiday season!

Paris, December 17, 2021 - Scutum Group and GENEO Partenaires announce the implementation of the [first] Obligation Relance, within the framework of the programme subscribed by the insurers and partially guaranteed by the State.

74 Human & Work managers and employees from all the group's brands, countries and businesses have decided to become shareholders and to unite their destiny to build, by 2025, the European leader in Human at Work.

As part of the implementation of the new Recovery Bonds, TURENNE GROUPE and GENEO Partenaires have 220 million euros available to enable SMEs and ETIs to finance their future projects by turning the page on the health crisis.

Paris, 15 November 2021 - French leader in childcare services, the Kinougarde group now benefits from the financial and strategic support of RAISE Investissement and GENEO Capital Entrepreneur to accelerate its growth.

Find the 11th GENEO Newsletter with news: Our new activity report, a new participation and the expansion of the team

Leader Group, a major international player in technological fire-fighting and rescue equipment, is supported by GENEO Capital Entrepreneur in an LMBO advised by the Mazars M&A team.

With 25 years of experience in SME and ETI financing, Mathilde Paoli joins GENEO Partenaires

Since the creation of ConvictionsRH, the 180 employees and the 5 founding partners of the Group

Find the 11th GENEO Newsletter with news: Our new activity report, a new participation and the expansion of the team

The crisis we are experiencing is probably one of the most serious that living generations have known. Social before economic, it invites us to take a step back on the structure of our economy and the models that we want to promote within our society: our health and social cohesion systems, our modes of nutrition, our places and ways of life, but also the business models and directions of growth tomorrow. To bounce back, we will have to reconcile resilience, pugnacity and a spirit of conquest.

The GBNA Group of private clinics calls on GENEO and UI to implement its investment programme and intensify its geographical development in the Nouvelle-Aquitaine region

On 25 March 2019, Human & Work welcomed GENEO Capital Entrepreneur to its capital, alongside 24 managers of the company. The objective is clear: to build a leading European consulting group in the field of human resources at work, based on a platform of unique expertise such as psychological health at work, gender equality and outplacement.

The Piscines Magiline group is reorganizing its capital around its manager, Mr. Hervé Ricard, who becomes the majority shareholder, the members of its management committee, the investment company GENEO Capital Entrepreneur, a new entrant, and Bpifrance, already a shareholder since 2016.

One year after the investment of GENEO Capital Entrepreneur, Dickson PTL, now OTEGO, has completed its independence.

Founded in 1980 by Michel Denis, Delta Service Location (DSL) is a pioneer in the rental of pumping equipment and generators for the construction, energy and industrial maintenance sectors.

On Thursday 8 October 2020, BBL Invest, the holding company of BBL Group, signed a capital agreement with the investment company GENEO Capital Entrepreneur. This operation for a total amount of 15 Million Euros strengthens the BBL Group's equity capital and provides it with long-term resources to finance its growth.

Arnaud has the dual mission, on the one hand, to organize the support functions within a general secretariat, and on the other hand, to take the lead in investor relations and to animate the GENEO Community.

Find the 5th GENEO Newsletter with the news: 200 million euros of surveys, the adoption of a raison d'être, a new participation, and the expansion of the team

ConvictionsRH announces the capital increase of 10 new Partners as well as a new institutional investor, GENEO Capital Entrepreneur. Sustained growth for a consulting firm that focuses on human capital

"We will strengthen our governance by setting up a 'Stakeholder Committee', which will be the guardian of our commitments to positive finance

An emblematic figure of entrepreneurship, Fanny Letier embarked on her own adventure in 2019 by creating the investment company Geneo alongside François Rivolier, with the support of 70 entrepreneurial families. Fanny Letier, who was Secretary General of the Interministerial Committee for Industrial Restructuring (Ciri) at the age of 29, was succeeded by Christine Lagarde, Arnaud Montebourg's former deputy chief of staff at Bercy, and spent five years as Bpifrance's number two.

For François Rivolier and Fanny Letier, co-founders of Geneo Capital Entrepreneur, the ability of companies to bounce back will be intimately linked to the definition of their raison d'être.

{{ vc_btn: title=T%C3%A9l%C3%A9charger+l%27article&color=primary&align=center&link=url%3Ahttps%253A%252F%252Fgeneocapitalentrepreneur.com%252Fwp-content%252Fuploads%252F2020%252F06%252FFigaro-Le-travail-demain.pdf%7C%7C%7C }}

GENEO Capital Entrepreneur is once again expanding its team and welcomes Marie Kirch as Investment Manager.

Discover the 2019 annual report

The Human & Work Group announces the acquisition of Psya, the pioneer in psychological and social support.

Find out more about GENEO's new investments and get news about our holdings!

The positive impact also means providing concrete support to the companies invested and helping them to implement their ideas.

Dickson PTL is a global specialist in the manufacture of technical fabrics for industrial markets.

The KARDHAM Group, the leading independent and integrated French player in the professional real estate sector, announces the acquisition of GENEO Capital Entrepreneur.

Valtus, the French and European leader in premium interim management, welcomes GENEO Capital Entrepreneur to its capital

Discover our 3rd participation, the new members of the team and especially the Community platform

The aim of this strategic alliance is to support hospitals and clinics in their digital transformation.

Find our 2nd investment. Take news of Human-Work. Meet GENEO in the Region

The PINETTE P.E.I. Group is the world leader in composite material parts forming equipment.

Finance must help companies through these cycles to ensure their sustainability and sustainable growth.

No, it is not innate. To know how to decide is a talent that is cultivated, even a skill perfectible, according to two specialists who have just released a book on the subject.

The SCR created by Fanny Letier and François Rivolier has 100 million euros, gathered with some fifty entrepreneurs or family investors.

Co-founder of Geneo Capital Entrepreneur, Fanny LETIER defends the idea of a fair sharing of wealth.

The former number two of Bpifrance is self-employed to invest in small and medium-sized enterprises over the long term and help them "double in size".

GENEO is launched, find out what the Growth Book is and above all which is geneO's first participation

Fanny LETIER and François RIVOLIER are pleased to announce the appointment...

GENEO invests in the human & work project group created in 2016 by entrepreneur David Mahé.

A new form of investment capital for SMEs and ETI

Delphine JARNIER joins Fanny LETIER and François RIVOLIER as associate director...

A book that aims to "awaken growth in the fabric of SMEs in France".

To remain itself (...), France certainly needs growth. But it needs long-term growth